drugset / Press release
Phase 1 Data for Flotetuzumab, MacroGenics' CD123 x CD3 DART® Molecule, Presented at 59th Annual ASH Meeting
2017-12-11 · MacroGenics · original macrogenics.com ↗
Phase 1 Data for Flotetuzumab, MacroGenics' CD123 x CD3 DART® Molecule, Presented at 59th Annual ASH Meeting 20.5 KB
The release as fetched from its publisher. macrogenics.com ↗